MFM
REGN icon

MD Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History

MD Financial Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2.43M Buy
3,852
+722
+23% +$444K 0.06% 165
2021
Q3 		$1.89M Sell
3,130
-1,598
-34% -$992K 0.05% 198
2021
Q2 		$2.64M Buy
+4,728
New +$2.4M 0.08% 110

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

MD Financial Management's REGN Position: Q4 2021 in Review

MD Financial Management increased its Regeneron Pharmaceuticals (REGN) stake by 23% in Q4 2021, buying an estimated $444K and bringing the position to 3,852 shares worth $2.43M. The position accounts for 0.06% of the portfolio, ranked #165.

MD Financial Management first reported a position in REGN in Q2 2021 and has held it in 3 quarters since. The position peaked at $2.64M in Q2 2021. 1,079 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

  • MD Financial Management held 3,852 shares of Regeneron Pharmaceuticals worth $2.43M as of Q4 2021.
  • MD Financial Management bought 722 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $444K.
  • Regeneron Pharmaceuticals made up 0.06% of MD Financial Management's portfolio in Q4 2021, its #165 holding.
  • MD Financial Management first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 3 quarters since.
  • MD Financial Management's Regeneron Pharmaceuticals position peaked at $2.64M in Q2 2021.
  • 1,079 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on MD Financial Management's 13F filing for Q4 2021, filed 14 Feb 2022.